Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study. (Record no. 16662052)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01863 a2200553 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250515045106.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 200701s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 0007-0920 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1038/sj.bjc.6603440 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Pittman, K B |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20070116 |
245 00 - TITLE STATEMENT | |
Title | Gemcitabine and carboplatin in carcinoma of unknown primary site: a phase 2 Adelaide Cancer Trials and Education Collaborative study. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | British journal of cancer |
Date of publication, distribution, etc. | Nov 2006 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 1309-13 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adenocarcinoma |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Adult |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Aged, 80 and over |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Australia |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carboplatin |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Carcinoma, Large Cell |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Deoxycytidine |
General subdivision | administration & dosage |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Female |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Male |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Maximum Tolerated Dose |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Middle Aged |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Neoplasms, Unknown Primary |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prognosis |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Prospective Studies |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Survival Rate |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Treatment Outcome |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Gemcitabine |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Olver, I N |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Koczwara, B |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Kotasek, D |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Patterson, W K |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Keefe, D M |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Karapetis, C S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Parnis, F X |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Moldovan, S |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Yeend, S J |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Price, T J |
773 0# - HOST ITEM ENTRY | |
Title | British journal of cancer |
Related parts | vol. 95 |
-- | no. 10 |
-- | p. 1309-13 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1038/sj.bjc.6603440">https://doi.org/10.1038/sj.bjc.6603440</a> |
Public note | Available from publisher's website |
No items available.